BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2119427)

  • 1. Inhibin secretion after treatment with an LHRH agonist and subsequent ovarian hyperstimulation induced by FSH in the macaque (Macaca arctoides).
    Fraser HM; Smith KB; Reddi K; Lunn SF
    J Reprod Fertil; 1990 Jul; 89(2):441-6. PubMed ID: 2119427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting gonadotrophin releasing hormone agonist implant causes variable duration of suppression of ovarian steroid and inhibin secretion.
    Fraser HM; Haining R; Cowen GM; Sandow J; Smith KB; Smith SK
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):97-104. PubMed ID: 1559303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive inhibin concentrations in serum throughout the menstrual cycle of the macaque: suppression of inhibin during the luteal phase after treatment with an LHRH antagonist.
    Fraser HM; Robertson DM; De Kretser DM
    J Endocrinol; 1989 Apr; 121(1):R9-12. PubMed ID: 2497222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of progesterone and inhibin secretion during the luteal phase in the macaque.
    Smith KB; Fraser HM
    J Endocrinol; 1991 Jan; 128(1):107-13. PubMed ID: 1900319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
    Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibin secretion by the sheep ovary during the luteal and follicular phases of the oestrous cycle and following stimulation with FSH.
    Tsonis CG; McNeilly AS; Baird DT
    J Endocrinol; 1988 May; 117(2):283-91. PubMed ID: 3132526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purified FSH stimulates production of inhibin by the human ovary.
    Buckler HM; Healy DL; Burger HG
    J Endocrinol; 1989 Jul; 122(1):279-85. PubMed ID: 2504869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid inhibitory effects of an LHRH agonist implant on the oestrogen-induced LH surge and the induction of a defective luteal phase after an agonist-induced ovulation in the macaque.
    Fraser HM; Lunn SF
    Hum Reprod; 1989 Jul; 4(5):506-12. PubMed ID: 2507574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women.
    Welt CK; Martin KA; Taylor AE; Lambert-Messerlian GM; Crowley WF; Smith JA; Schoenfeld DA; Hall JE
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2645-52. PubMed ID: 9253348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of late follicular phase administration of antide on ovulation and inhibin secretion in macaques.
    Fraser HM; Lunn SF; Cowen GM; Smith KB; Conn PM
    Contraception; 1991 Dec; 44(6):667-76. PubMed ID: 1773623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone-releasing hormone agonist and exogenous gonadotropin administration.
    Buckler HM; McLachlan RI; MacLachlan VB; Healy DL; Burger HG
    J Clin Endocrinol Metab; 1988 Apr; 66(4):798-803. PubMed ID: 3126215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor acts directly on the sheep ovary in vivo to inhibit oestradiol-17 beta and inhibin secretion and enhance progesterone secretion.
    Murray JF; Downing JA; Evans G; Findlay JK; Scaramuzzi RJ
    J Endocrinol; 1993 May; 137(2):253-64. PubMed ID: 8326252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a potent gonadotrophin-releasing hormone antagonist on ovarian secretion of oestradiol, inhibin and androstenedione and the concentration of LH and FSH during the follicular phase of the sheep oestrous cycle.
    Campbell BK; McNeilly AS; Picton HM; Baird DT
    J Endocrinol; 1990 Sep; 126(3):377-84. PubMed ID: 2120381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey.
    Fraser HM; Sandow J
    J Clin Endocrinol Metab; 1985 Mar; 60(3):579-84. PubMed ID: 3919049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of dimeric inhibins, activin A, gonadotrophins and ovarian steroids during the menstrual cycle in older women.
    Muttukrishna S; Child T; Lockwood GM; Groome NP; Barlow DH; Ledger WL
    Hum Reprod; 2000 Mar; 15(3):549-56. PubMed ID: 10686195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of inhibin during the luteal-follicular phase transition of the primate menstrual cycle fails to affect FSH secretion.
    Fraser HM; Tsonis CG
    J Endocrinol; 1994 Jul; 142(1):181-6. PubMed ID: 7964278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between inhibin, oestradiol and progesterone in the control of gonadotrophin secretion in the ewe.
    Martin GB; Price CA; ThiƩry JC; Webb R
    J Reprod Fertil; 1988 Jan; 82(1):319-28. PubMed ID: 3123665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of FSH on serum immunoreactive inhibin levels in the luteal phase of the menstrual cycle.
    Burger H; Hee J; Bangah M; Prince M; McCloud P; Ohara A; Iwai T; Mori T
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):431-4. PubMed ID: 8959081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer.
    Lockwood GM; Muttukrishna S; Groome NP; Knight PG; Ledger WL
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):741-8. PubMed ID: 9039341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.